Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

Minna Tanner, Jorma Isola, Tom Wiklund, Bjorn Erikstein, Pirkko Kellokumpu-Lehtinen, Per Malmström, Nils Wilking, Jonas Nilsson, Jonas Bergh

Research output: Contribution to journalArticlepeer-review

212 Citations (SciVal)
Original languageEnglish
Pages (from-to)2428-2436
JournalJournal of Clinical Oncology
Issue number16
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Cancer and Oncology

Cite this